• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自缺氧乳腺癌细胞外泌体的lnc-MTRNR2L12-3通过Src/FAK信号通路促进血管生成。

lnc-MTRNR2L12-3 derived from hypoxic breast cancer cell exosomes facilitates angiogenesis via the Src/FAK signaling pathway.

作者信息

Zheng Li, Mo Juanfen, He Xuesong, Xu Qi, Bao Yi, Wu Jiayuan

机构信息

The Key Laboratory, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, People's Republic of China.

Department of Breast Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, People's Republic of China.

出版信息

Med Oncol. 2025 Jun 25;42(8):280. doi: 10.1007/s12032-025-02836-9.

DOI:10.1007/s12032-025-02836-9
PMID:40560294
Abstract

Exosomal long non-coding RNAs (lncRNAs) play crucial roles in breast cancer progression. However, the mechanisms by which hypoxia-induced exosomes mediate angiogenesis through lncRNAs in the tumor microenvironment remain largely unexplored. In this study, exosomes were isolated and characterized from MDA-MB-231 breast cancer cells under normoxic and hypoxic conditions. Hypoxia-induced exosomes (Hyp-exo) were shown to significantly promote angiogenesis. Microarray analysis revealed that lnc-MTRNR2L12-3 was highly enriched in Hyp-exo compared to normoxic exosomes (NC-exo). Functional studies, both in vitro and in vivo, demonstrated that exosomal lnc-MTRNR2L12-3 derived from hypoxic breast cancer cells substantially enhanced angiogenesis. Mechanistically, PCR array and western blot analysis confirmed that silencing lnc-MTRNR2L12-3 inhibited Src/FAK signaling pathway activation in HUVECs, while hypoxia-induced exosomes effectively rescued this suppression. Overall, hypoxia-induced breast cancer exosomes deliver lnc-MTRNR2L12-3 to endothelial cells, promoting angiogenesis through the Src/FAK signaling pathway. These findings provide new insights into targeting angiogenesis in the tumor microenvironment for breast cancer therapy.

摘要

外泌体长链非编码RNA(lncRNAs)在乳腺癌进展中发挥着关键作用。然而,缺氧诱导的外泌体通过lncRNAs在肿瘤微环境中介导血管生成的机制在很大程度上仍未被探索。在本研究中,从常氧和缺氧条件下的MDA-MB-231乳腺癌细胞中分离并鉴定了外泌体。结果显示,缺氧诱导的外泌体(Hyp-exo)能显著促进血管生成。微阵列分析表明,与常氧外泌体(NC-exo)相比,lnc-MTRNR2L12-3在Hyp-exo中高度富集。体外和体内的功能研究均表明,源自缺氧乳腺癌细胞的外泌体lnc-MTRNR2L12-3能显著增强血管生成。从机制上来说,PCR阵列和蛋白质印迹分析证实,沉默lnc-MTRNR2L12-3可抑制人脐静脉内皮细胞(HUVECs)中Src/FAK信号通路的激活,而缺氧诱导的外泌体能有效挽救这种抑制作用。总体而言,缺氧诱导的乳腺癌外泌体将lnc-MTRNR2L12-3传递给内皮细胞,通过Src/FAK信号通路促进血管生成。这些发现为针对肿瘤微环境中的血管生成进行乳腺癌治疗提供了新的见解。

相似文献

1
lnc-MTRNR2L12-3 derived from hypoxic breast cancer cell exosomes facilitates angiogenesis via the Src/FAK signaling pathway.源自缺氧乳腺癌细胞外泌体的lnc-MTRNR2L12-3通过Src/FAK信号通路促进血管生成。
Med Oncol. 2025 Jun 25;42(8):280. doi: 10.1007/s12032-025-02836-9.
2
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis.外泌体来源的lnc-FAM72D-3通过MBNL1/FAK轴重塑肝细胞癌细胞骨架促进乐伐替尼耐药。
Drug Resist Updat. 2025 Sep;82:101271. doi: 10.1016/j.drup.2025.101271. Epub 2025 Jun 7.
3
Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.低氧骨髓间充质干细胞来源的外泌体通过转移 miR-126 促进骨骨折愈合。
Acta Biomater. 2020 Feb;103:196-212. doi: 10.1016/j.actbio.2019.12.020. Epub 2019 Dec 17.
4
Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression.外泌体长链非编码 RNA SNHG12 促进血管生成和乳腺癌进展。
Breast Cancer. 2024 Jul;31(4):607-620. doi: 10.1007/s12282-024-01574-6. Epub 2024 Jun 4.
5
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head.来自成脂骨髓间充质干细胞的外泌体SPRY4通过PTPRB/TIE2/PI3K轴损害激素性股骨头坏死中的血管生成。
Stem Cell Res Ther. 2025 Jul 15;16(1):375. doi: 10.1186/s13287-025-04505-0.
6
Rab27aCAF exosomal miR-9-5p promotes osteosarcoma progression via CREBRF/MAPK signaling pathway.Rab27aCAF外泌体miR-9-5p通过CREBRF/MAPK信号通路促进骨肉瘤进展。
Cell Signal. 2025 Oct;134:111964. doi: 10.1016/j.cellsig.2025.111964. Epub 2025 Jun 26.
7
Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p/NOTCH1 signaling.缺氧的癌症相关成纤维细胞外泌体环状STAT3通过miR-671-5p/NOTCH1信号传导驱动三阴性乳腺癌干性。
J Transl Med. 2025 Jul 23;23(1):814. doi: 10.1186/s12967-025-06794-8.
8
Suppression of human MDA-MB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase.U6 启动子驱动的靶向粘着斑激酶短发夹 RNA 对人 MDA-MB-435S 肿瘤的抑制作用。
J Cancer Res Clin Oncol. 2010 Aug;136(8):1229-42. doi: 10.1007/s00432-010-0773-3. Epub 2010 Feb 7.
9
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression.循环中外泌体相关的MTA1在乳腺癌进展过程中升高。
FASEB J. 2025 Jul 31;39(14):e70872. doi: 10.1096/fj.202500221R.
10
Exosomal miR-382-5p prevents pre-metastatic niche formation by inhibiting GPR176/GNAS-CXCR1/CXCR2 axis in colorectal cancer liver metastasis.外泌体miR-382-5p通过抑制结直肠癌肝转移中的GPR176/GNAS-CXCR1/CXCR2轴来阻止前转移生态位的形成。
Cell Signal. 2025 Oct;134:111963. doi: 10.1016/j.cellsig.2025.111963. Epub 2025 Jun 25.

本文引用的文献

1
Investigating intra-tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single-cell RNA sequencing.通过单细胞RNA测序研究原发性心脏血管肉瘤的肿瘤内异质性和微环境多样性。
Clin Transl Med. 2024 Dec;14(12):e70113. doi: 10.1002/ctm2.70113.
2
Targeted and cytotoxic inhibitors used in the treatment of breast cancer.用于治疗乳腺癌的靶向性和细胞毒性抑制剂。
Pharmacol Res. 2024 Dec;210:107534. doi: 10.1016/j.phrs.2024.107534. Epub 2024 Dec 2.
3
Breast cancer statistics 2024.2024 年乳腺癌统计数据。
CA Cancer J Clin. 2024 Nov-Dec;74(6):477-495. doi: 10.3322/caac.21863. Epub 2024 Oct 1.
4
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies.乳腺癌:益处、弊端及对有效降低风险策略的重要呼吁。
CA Cancer J Clin. 2024 Nov-Dec;74(6):471-474. doi: 10.3322/caac.21867. Epub 2024 Oct 1.
5
Identification of the novel exhausted T cell CD8 + markers in breast cancer.鉴定乳腺癌中新型耗竭 T 细胞 CD8+标志物。
Sci Rep. 2024 Aug 19;14(1):19142. doi: 10.1038/s41598-024-70184-1.
6
Cancer treatments: Past, present, and future.癌症治疗:过去、现在和未来。
Cancer Genet. 2024 Aug;286-287:18-24. doi: 10.1016/j.cancergen.2024.06.002. Epub 2024 Jun 17.
7
SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1.SP1 诱导的 circ_0017552 通过上调 NET1 调节结肠癌细胞增殖和凋亡。
Cancer Genet. 2024 Aug;286-287:1-10. doi: 10.1016/j.cancergen.2024.05.002. Epub 2024 May 12.
8
hsa-miR-CHA2, a novel microRNA, exhibits anticancer effects by suppressing cyclin E1 in human non-small cell lung cancer cells.hsa-miR-CHA2,一种新型 microRNA,通过抑制人非小细胞肺癌细胞中的 cyclin E1 发挥抗癌作用。
Biochim Biophys Acta Mol Basis Dis. 2024 Aug;1870(6):167250. doi: 10.1016/j.bbadis.2024.167250. Epub 2024 May 18.
9
Altered cancer metabolism and implications for next-generation CAR T-cell therapies.改变的癌症代谢和对下一代 CAR T 细胞疗法的影响。
Pharmacol Ther. 2024 Jul;259:108667. doi: 10.1016/j.pharmthera.2024.108667. Epub 2024 May 17.
10
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.长链非编码 RNA FOXD2-AS1 通过调控 miR-185-5p/PLOD1/Akt/mTOR 通路促进口腔鳞状细胞癌细胞的生长、侵袭和迁移。
Cancer Genet. 2024 Jun;284-285:48-57. doi: 10.1016/j.cancergen.2024.05.001. Epub 2024 May 6.